RxDoctor Payments Data

Margaret Livingston

Obstetrics & Gynecology · West Des Moines, IANPI 1396874673

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $7,616 of the $8,968 with a category attached, or 84.9%. Organon accounts for 85.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $4,235 and has fallen 52.8% since, to $1,999 in 2025. Among obstetrics & gynecology clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,968in general payments, 2019–2025

Across 81 payments — averaging $110.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$8K
  • Astellas Pharma US Inc$254
  • Bayer$178
  • Mayne Pharma Commercial LLC$136
  • Hologic Sales And Service, LLC$131
  • AbbVie$114
  • plus $487 from 9 others

What the payments were for

  • Speaking & faculty fees$7,61685%
  • Food & beverage$1,25314%
  • Education$991%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,968 in reported general payments places this provider in the 95th percentile of 274 obstetrics & gynecology providers in Iowa.

See all obstetrics & gynecology providers in Iowa

Medicare billing

Part B allowed, 2024
$2,997
Medicare patients
31
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol28$1,914
Estradiol (Twice Weekly)Estradiol18$812

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →